Clinical trials
Trials in Luxembourg with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2014 | 3 |
| 2015 | 1 |
| 2017 | 6 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 6 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 6 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
| Recruiting | 8 |
| Unknown status | 6 |
| Active, not recruiting | 5 |
| Terminated | 2 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Luxembourg Institute of Health | 12 |
| Centre Hospitalier du Luxembourg | 4 |
| University of Luxembourg | 4 |
| Jules Bordet Institute | 2 |
| Region Skane | 2 |
| University of Cambridge | 2 |
| AOTI Ltd. | 1 |
| Association Francaise pour la Recherche Thermale | 1 |
| Centre Francois Baclesse, Luxembourg | 1 |
| Centre National de Rééducation Fonctionnelle et de Réadaptation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 1 | 6 |
| Breast Neoplasms | 5 |
| Post-Acute COVID-19 Syndrome | 3 |
| Colonic Neoplasms | 2 |
| Fibrosis | 2 |
| Heart Arrest | 2 |
| Hypoxia, Brain | 2 |
| Neoplasm Metastasis | 2 |
| Neoplasms | 2 |
| Obesity | 2 |
Trials
Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.